BioSpace News Archive

Reference is made to the stock exchange announcement regarding the successful completion of the private placement of Nordic Nanovector ASA published on 25 January 2019.

Series celebrates seventh consecutive year providing a benchmark for payment technology & adoption in industries including ARM, Financial Services and Healthcare

Results of a clinical study recently published in the scientific journal “The International journal of Lower Extremity Wound” show Nexodyn® AcidOxidizing Solution, the Tehclo based cleanser for acute and chronic wound care developed by the Swiss pharma company APR Applied Pharma Research S.A., to promote the restart of wound healing process.

Baylis Medical is pleased to announce that seasoned marketing executive Gloria Yee has joined Baylis as its Vice President of Marketing.

Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the fourth quarter and full year ended December 31, 2018.

Knopp Biosciences LLC announced that the management will present and conduct face-to-face meetings at the 2019 BIO CEO & Investor Conference, to be held in New York, NY on February 11-12.

Dewpoint Therapeutics, a company translating the emerging area of biomolecular condensates into drug discovery, launched with a $60 million Series A.

Prof. Fred Witjes, Radboud University Medical Center: “Because of the exceptional, clinically-proven, high performance of Bladder EpiCheck, we can now substitute an invasive procedure for detecting recurrent bladder cancer with a simple urine test”

Transaction included $3M of preferred shares, and the elimination of $2M of debt

IQVIA Holdings Inc., will announce its fourth-quarter and full-year 2018 financial results and issue 2019 guidance before the market opens on Thursday, February 14, 2019.